TACE-induced tumor necrosis releases tumor antigens, enhancing antitumor immune responses, creating a pro-vascular environment for targeted therapy, and augmenting CD8+ T cell responses to tumor-associated antigens (TAAs). This evidence concerns the gene CD8A and neoplasm.